Reaction
Malignant Hypertension reporting signals
As of the last recalculation, Malignant Hypertension appears in 849 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is CEFAZOLIN (PRR 27.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cefazolin | 10 | 27.2 | 27.2 |
| Labetalol | 13 | 24.3 | 24.3 |
| Cefazolin Sodium | 11 | 22.7 | 22.7 |
| Clonidine | 40 | 20.0 | 20.1 |
| Terazosin Hydrochloride | 7 | 19.4 | 19.5 |
| Eculizumab | 36 | 16.9 | 16.9 |
| Atazanavir | 9 | 15.5 | 15.5 |
| Carfilzomib | 9 | 7.9 | 7.9 |
| Axitinib | 6 | 7.6 | 7.6 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 6.7 | 6.7 |
| Minoxidil Foam 5% (Womens) | 7 | 5.2 | 5.2 |
| Minoxidil | 7 | 3.8 | 3.8 |